IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Diadema Partners LP

Q2 2026 Holdings

Filed 2026-08-14 | 149 holdings | $791.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Viking Therapeutics Inc(VKTX)CallCOM92686J106$47.6M1,220,8006.0%
Abivax SA(ABVX)CallSPONSORED ADS00370M103$46.5M349,2005.9%
Bristol-Myers Squibb Co(BMY)CallCOM110122108$34.6M600,0004.4%
Abivax SA(ABVX)PutSPONSORED ADS00370M103$33.6M252,4004.3%
United Therapeutics Corp del(UTHR)COM91307C102$28.7M52,9893.6%
Revolution Medicines Inc(RVMD)COM76155X100$26.1M139,2183.3%
Abivax SA(ABVX)SPONSORED ADS00370M103$21.6M163,6442.7%
Cogent Biosciences Inc(COGT)COM19240Q201$19.1M493,6642.4%
Bristol-Myers Squibb Co(BMY)PutCOM110122108$19.0M330,6002.4%
Bridgebio Pharma IncNOTE 1.750% 3/010806XAJ1$18.6M$250,0002.4%
Corcept Therapeutics Inc(CORT)CallCOM218352102$17.9M206,3002.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$17.9M312,8462.3%
Viking Therapeutics Inc(VKTX)COM92686J106$17.2M441,8082.2%
Kymera Therapeutics Inc(KYMR)CallCOM501575104$17.2M149,7002.2%
Novartis AG(NVSN)PutSPONSORED ADR66987V109$15.7M100,0002.0%
Uniqure NV(QURE)PutSHSN90064101$13.8M299,0001.7%
Viking Therapeutics Inc(VKTX)PutCOM92686J106$13.7M350,5001.7%
Biogen Inc(BIIB)CallCOM09062X103$13.0M60,0001.6%
Capricor Therapeutics Inc(CAPR)PutCOM NEW14070B309$12.9M534,4001.6%
Summit Therapeutics Inc(SMMT)CallCOM86627T108$12.5M860,2001.6%
ELI Lilly & Co(LLY)PutCOM532457108$12.0M10,0001.5%
Incyte Corp(INCY)PutCOM45337C102$11.9M105,4001.5%
Edgewise Therapeutics Inc(EWTX)COM28036F105$11.1M272,2141.4%
Uniqure NV(QURE)CallSHSN90064101$10.8M235,4001.4%
Biontech SE(BNTX)CallSPONSORED ADS09075V102$9.3M100,0001.2%
Kodiak Sciences Inc(KOD)COM50015M109$8.5M218,1171.1%
Immunocore Hldgs PLC(IMCR)ADS45258D105$8.1M254,8631.0%
Capricor Therapeutics Inc(CAPR)CallCOM NEW14070B309$7.9M329,3001.0%
Novartis AG(NVSN)CallSPONSORED ADR66987V109$7.8M50,0001.0%
Replimune Group Inc(REPL)CallCOM76029N106$7.7M696,3001.0%
Kodiak Sciences Inc(KOD)CallCOM50015M109$7.7M196,7001.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$7.6M571,1071.0%
Moderna Inc(MRNA)PutCOM60770K107$7.0M100,0000.9%
Hims & Hers Health Inc(HIMS)CallCOM CL A433000106$6.9M200,0000.9%
Arcus Biosciences Inc(RCUS)COM03969F109$6.9M223,8100.9%
Hims & Hers Health Inc(HIMS)PutCOM CL A433000106$6.7M193,7000.8%
Corbus Pharmaceuticals Hldgs(CRBP)CallCOM NEW21833P301$5.9M633,8000.8%
Sellas Life Sciences Group I(SLS)CallCOM NEW81642T209$5.9M400,0000.7%
Kodiak Sciences Inc(KOD)PutCOM50015M109$5.7M146,9000.7%
Alumis Inc(ALMS)CallCOM022307102$5.6M200,0000.7%
Royalty Pharma PLC(RPRX)CallSHS CLASS AG7709Q104$5.6M100,0000.7%
Johnson & Johnson(JNJ)COM478160104$5.6M22,0000.7%
Replimune Group Inc(REPL)PutCOM76029N106$5.6M502,5000.7%
Bioage Labs Inc(BIOA)CallCOM09077V100$4.9M200,1000.6%
Novo-Nordisk A S(NVO)ADR670100205$4.8M100,0000.6%
Biohaven LTD(BHVN)CallCOMG1110E107$4.7M317,0000.6%
Tenax Therapeutics Inc(TENX)CallCOM NEW88032L605$4.5M307,0000.6%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$4.4M294,8110.6%
Relay Therapeutics Inc(RLAY)COM75943R102$4.3M230,6770.5%
TG Therapeutics Inc(TGTX)CallCOM88322Q108$4.2M75,7000.5%
Page 1 of 3Next